Multidisciplinary Decision-Making-ITAlian Consensus After Two Years of Real Practice on the Management of Severe Uncontrolled CRSwNP by Biologics (ITACA Study)
Giovedì 22 agosto 2024
ca. 1 min. di lettura
Journal and Affiliations:
Current Allergy and Asthma Reports, =marzo 2024
Matteo Trimarchi, Otorinolaringoiatria - Chirurgia della testa e del collo, EOC e USI, Ospedale regionale, Lugano
Tags:
biological therapy
chronic rhinosinusitis with nasal polyps
dupilumab
mepolizumab
multidisciplinary management
omalizumab
response assessment
type 2 inflammation
Authors:
Matteo Trimarchi